Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 139 results for "arun sawhney"

Indian drugmaker Ranbaxy still has exclusive rights for Nexium generic: CEO
Reuters

Indian drugmaker Ranbaxy still has exclusive rights for Nexium...

Ranbaxy Laboratories's Chief Executive Arun Sawhney poses for a picture at his office in Gurgaon on the outskirts of New Delhi June 13, 2013. Credit: Reuters/Adnan Abidi (Reuters) - Indian drugmaker Ranbaxy Laboratories still has exclusive ... Reuters, 1 month ago
[x]  

2 images for "arun sawhney"

Reuters India, 1 month ago
Yahoo! News, 1 month ago

Sawhney assails NC, Cong for plundering public wealth

Excelsior Correspondent JAMMU, Nov 23: Independent candidate from Jammu West, Arun Sawhney, today attacked both NC and Congress for plundering public wealth openly and shamelessly. Addressing a public meeting at Bakshi Nagar, he came heavily on ...
 Daily Excelsior.com4 weeks ago

Ranbaxy Laboratories : Labs to take its novel drug Synriam to Africa

Mumbai : Drug manufacturer Ranbaxy Laboratories said that it has received regulatory approval to launch its new chemical entity (NCE) Synriam in seven African countries namely Nigeria , Uganda , Senegal , Cameroon , Guinea , Kenya and Ivory Coast .
 4 Traders5 days ago Ranbaxy gets nod to sell drug treating malaria in 7 African nations  DNA India6 days ago
Business Standard India

Ranbaxy receives approval for malaria drug Synriam from 7 African countries

While the company has already launched the product in Uganda, it is planning to introduce the product in other six countries towards end of January 2015 BS B2B Bureau | Gurgaon December 16, 2014 Last Updated at 22:23 IST Ranbaxy Laboratories Limited ...
 Business Standard India5 days ago Ranbaxy to launch malaria drug in 7 African countries  Bio Spectrum Asia6 days ago Ranbaxy Gets the Nod to Commence Distribution of Its Anti-malarial Drug in 7 African Countries  MedIndia6 days ago Ranbaxy to launch India's first new chemical entity Synriam in seven African countries  PharmaBiz1 week ago
[x]  

Nifty ends above 8200, Sensex flat; HDFC up 5%, TCS dips 3%

03:30 pm Market closing Continuing its sluggish mode, the market ended flat. The Sensex was down 31.12 points at 27319.56 and the Nifty was down 4.50 points at 8219.60. About 1178 shares advanced, 1728 shares declined, and 108 shares were ...
 Moneycontrol.com1 week ago

Natco's CL for Nexavar survives Bayer's SLP

Natco has now won appeals at all three stages, from the the Intellectual Property Appellate Board (IPAB), High Court and now, the SC The Supreme Court of India (SC) has dismissed Bayer's Special Leave Petition (SLP) against India's first ...
 Financial Express1 week ago
International Business Times India

India,United States : CCI grants approval for SUN PHARMA and RANBAXY LABS merger [TendersInfo (India)]

The Competition Commission of India (CCI) has granted approval for the proposed merger between the Sun Pharma and Ranbaxy Labs. The merger will result in a combined entity with annual sales worth $4.3 billion, making it the fifth-largest generic ...
 Pharmacy Choice1 week ago Ranbaxy Posts Loss after Write-offs on US Import Bans  International Business Times India1 week ago CCI approves proposed merger between Sun Pharma and Ranbaxy  India Infoline1 week ago Ranbaxy and Sun Pharma merger approved  Pharmafocus1 week ago
[x]  

Blog: Modi government's doing fine, problem's with India Inc

By R Sriram Sarkaar sabka mai baap hai! Whenever there is a problem, everybody goes to them for help! The head of a large finance house who made this succinct analysis many years ago could not have anticipated the current situation where a ...
 Economic Times1 week ago
International Business Times India

Tracing Ranbaxy's Journey over the Years

Ranbaxy's Journey Ranbaxy is an India-based pharmaceutical company. Its subsidiary, Ohm Laboratories in the US, received an approval to launch a cheaper version of Novartis blood pressure and heart attack treatment pill, Diovan, from the US Food ...
 International Business Times India1 week ago Ranbaxy Q2 net profit up  Individual.com1 month ago Pharmaceuticals Newsletter - October 27 to 31, 2014  India Infoline1 month ago Ranbaxy Back in Black with Rs 478 cr Profit  New Indian Express1 month ago
[x]  

Initial euphoria wanes, India Inc worried about Modi government's 'lack of boldness'

NEW DELHI: Six months after Modi Sarkar assumed power amidst great expectations, many industrialists are concerned about what they see as a lack of boldness in reforms and an absence of radical ideas. As a result, they are largely unwilling to ...
 Times of India1 week ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less